share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:拟议出售证券
美股SEC公告 ·  2024/11/05 05:45

Moomoo AI 已提取核心信息

Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,015 shares of common stock on 11/04/2024, as per the latest filing. The shares, acquired on 11/01/2024 through a restricted stock vest from Arcutis Biotherapeutics, have an aggregate market value of $43,551. This transaction follows a period where no other sales were reported in the past three months.
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,015 shares of common stock on 11/04/2024, as per the latest filing. The shares, acquired on 11/01/2024 through a restricted stock vest from Arcutis Biotherapeutics, have an aggregate market value of $43,551. This transaction follows a period where no other sales were reported in the past three months.
arcutis biotherapeutics公司高管松田胜计划在2024年11月4日卖出共计5,015股普通股,最新申报显示。这些股票是通过arcutis biotherapeutics的限制性股票授予计划于2024年11月1日获得的,市值合计为$43,551。这项交易是在过去三个月没有其他销售报告的情况下进行的。
arcutis biotherapeutics公司高管松田胜计划在2024年11月4日卖出共计5,015股普通股,最新申报显示。这些股票是通过arcutis biotherapeutics的限制性股票授予计划于2024年11月1日获得的,市值合计为$43,551。这项交易是在过去三个月没有其他销售报告的情况下进行的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息